ES549822A0 - Procedimiento para la preparacion de derivados n-acilados del-triptofano - Google Patents

Procedimiento para la preparacion de derivados n-acilados del-triptofano

Info

Publication number
ES549822A0
ES549822A0 ES549822A ES549822A ES549822A0 ES 549822 A0 ES549822 A0 ES 549822A0 ES 549822 A ES549822 A ES 549822A ES 549822 A ES549822 A ES 549822A ES 549822 A0 ES549822 A0 ES 549822A0
Authority
ES
Spain
Prior art keywords
group
substituted
derivatives
meta
mono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549822A
Other languages
English (en)
Other versions
ES8706630A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rottapharm SpA
Original Assignee
Rotta Research Laboratorium SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Laboratorium SpA filed Critical Rotta Research Laboratorium SpA
Publication of ES8706630A1 publication Critical patent/ES8706630A1/es
Publication of ES549822A0 publication Critical patent/ES549822A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES549822A 1984-12-12 1985-12-11 Procedimiento para la preparacion de derivados n-acilados del-triptofano Expired ES8706630A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT68241/84A IT1179866B (it) 1984-12-12 1984-12-12 Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono

Publications (2)

Publication Number Publication Date
ES8706630A1 ES8706630A1 (es) 1987-06-01
ES549822A0 true ES549822A0 (es) 1987-06-01

Family

ID=11308641

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549822A Expired ES8706630A1 (es) 1984-12-12 1985-12-11 Procedimiento para la preparacion de derivados n-acilados del-triptofano

Country Status (14)

Country Link
US (1) US4870097A (es)
EP (1) EP0237522B1 (es)
JP (1) JPS62501292A (es)
AT (1) ATE85976T1 (es)
AU (1) AU589938B2 (es)
CA (1) CA1256441A (es)
DE (1) DE3587122T2 (es)
DK (1) DK168564B1 (es)
ES (1) ES8706630A1 (es)
IE (1) IE58502B1 (es)
IT (1) IT1179866B (es)
PT (1) PT81674B (es)
WO (1) WO1986003489A1 (es)
ZA (1) ZA859526B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814463A (en) * 1985-12-31 1989-03-21 Biomeasure, Inc. CCK antagonists
US5089638A (en) * 1986-06-16 1992-02-18 Merck & Co., Inc. Amino acid analogs as CCK-antagonists
US4880938A (en) * 1986-06-16 1989-11-14 Merck & Co., Inc. Amino acid analogs
SE8901149D0 (sv) * 1989-04-03 1989-04-03 Pharmacia Ab Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
AU643365B2 (en) * 1991-02-28 1993-11-11 Aventisub Ii Inc. NMDA antagonists
US5360814A (en) * 1991-02-28 1994-11-01 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
US5484814A (en) * 1991-02-28 1996-01-16 Merrell Dow Pharmaceuticals Inc. NMDA antagonists
US20030199523A1 (en) * 2002-02-28 2003-10-23 Snutch Terrance P. Heterocyclic calcium in channel blockers
DK1549333T3 (da) 2002-09-20 2012-01-16 Univ Pennsylvania Compstatinanaloge med forbedret aktivitet
US8168584B2 (en) 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
CA2625206C (en) 2005-10-08 2021-12-07 Potentia Pharmaceuticals, Inc. Compstatin and analogs thereof for eye disorders
CN106188239B (zh) 2005-11-28 2020-01-07 宾夕法尼亚州大学理事会 有效的坎普他汀类似物
AU2008214359B2 (en) 2007-02-05 2014-01-16 Apellis Pharmaceuticals, Inc. Local complement inhibition for treatment of complement-mediated disorders
CN102458438A (zh) 2009-05-01 2012-05-16 宾夕法尼亚州大学理事会 具有肽骨架和c-末端修饰的经修饰补体抑素
CA2813049A1 (en) 2010-09-23 2012-03-29 The Trustees Of The University Of Pennsylvania Modified compstatin with improved stability and binding properties
CA2826019C (en) 2011-01-26 2017-08-01 Nico Worldwide Inc. Remedy for migraine headache
CA2835627C (en) 2011-05-11 2023-01-10 Apellis Pharmaceuticals, Inc. Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
EP2723361B1 (en) 2011-06-22 2019-10-30 Apellis Pharmaceuticals, Inc. Methods of treating chronic disorders with complement inhibitors
CA2847862C (en) 2011-09-07 2021-01-12 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved pharmacokinetic properties
EP3929206A1 (en) 2012-11-15 2021-12-29 Apellis Pharmaceuticals, Inc. Long-acting compstatin analogs and related compositions and methods
US10308687B2 (en) 2013-03-15 2019-06-04 Apellis Pharmaceuticals, Inc. Cell-penetrating compstatin analogs and uses thereof
WO2015142701A1 (en) 2014-03-17 2015-09-24 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved potency and pharmacokinetic properties
CA3287719A1 (en) 2015-10-07 2026-03-02 Apellis Pharmaceuticals, Inc. Use of long-acting compstatin analog for treating a complement-mediated disorder
JP2018534303A (ja) * 2015-11-12 2018-11-22 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク ポリミキシン系抗生物質に対する耐性グラム陰性細菌感染を標的にする合理的薬物設計
CN116059313A (zh) 2017-04-07 2023-05-05 阿佩利斯制药有限公司 给药方案以及相关组合物和方法
WO2018200381A1 (en) 2017-04-25 2018-11-01 Temple Otorongo Llc Pharmaceutical composition comprising tryptophan and phyllokinin derivative for use in treating psychiatric and psychological conditions
KR20240167712A (ko) 2017-12-15 2024-11-27 아펠리스 파마슈티컬스 인코포레이티드 투여 요법 및 관련 조성물 및 방법
WO2019195712A2 (en) 2018-04-06 2019-10-10 The Trustees Of The University Of Pennsylvania Compstatin analogs with increased solubility and improved pharmacokinetic properties

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1055518B (it) * 1971-05-18 1982-01-11 Rotta Research Lab Derivatives del triptofano
US4482567A (en) * 1982-10-07 1984-11-13 Research Foundation For Mental Hygiene, Inc. N-hexanoyl to n-heptadecanoyl 5-hydroxy tryptophan-5-hydroxytryptophanamides and use as analgesics

Also Published As

Publication number Publication date
IT8468241A0 (it) 1984-12-12
ATE85976T1 (de) 1993-03-15
ES8706630A1 (es) 1987-06-01
WO1986003489A1 (en) 1986-06-19
IE58502B1 (en) 1993-10-06
AU589938B2 (en) 1989-10-26
PT81674B (pt) 1987-10-20
EP0237522A1 (en) 1987-09-23
ZA859526B (en) 1986-08-27
EP0237522B1 (en) 1993-02-24
PT81674A (en) 1986-01-01
CA1256441A (en) 1989-06-27
DK168564B1 (da) 1994-04-25
DE3587122D1 (de) 1993-04-01
JPS62501292A (ja) 1987-05-21
DE3587122T2 (de) 1993-07-15
US4870097A (en) 1989-09-26
DK381486D0 (da) 1986-08-11
IE853029L (en) 1986-06-12
AU5209986A (en) 1986-07-01
IT8468241A1 (it) 1986-06-12
DK381486A (da) 1986-08-11
IT1179866B (it) 1987-09-16

Similar Documents

Publication Publication Date Title
DK381486D0 (da) N-acylerede derivater af l-tryptophan, deres fremstilling og anvendelse
ES519615A0 (es) Un procedimiento para la preparacion de nuevas 1,2,3,4-tetrahidro-2-naftilaminas.
ES2059069T3 (es) Nuevos derivados de 1-alcoxi-(2-acilamino-etil)-naftalenos y su procedimiento de preparacion.
ES8103744A1 (es) Un metodo para la preparacion de derivados de ftalimidina
DK282488A (da) Farmaceutiske praeparater, deri indgaaende phenylalkylaminger eller salte deraf og forbindelsernes fremstilling
ES526896A0 (es) Procedimiento para la preparacion de b-carbolinas
BR8707408A (pt) Novos 5-alcoxi-2,4-diamino-alquibenzenos e composicoes de tingimento de cabelo com 5-alcoxi-2,4-diamino-alquil-benzenos
DE3669149D1 (de) Substituierte p,p'-methylen-bis-aniline.
DE3260540D1 (en) 2-aryl-3,4-diaza-bicyclo(4.n.0)alken-(2)-ones-(5), process for their preparation, and medicines containing these compounds
EP0271013A3 (en) Basic substituted phenyl acetonitriles, their preparation and medicaments containing them
PT77666B (fr) Procede de preparation de nouveaux derives de la nitrosouree
MX158073A (es) Procedimiento para preparar dipropilamino-2-hidroxi-6-formilamino-5-o-tetrahidro-1,2-3,4,-naftaleno
ES550846A0 (es) Procedimiento para la obtencion de n-(fosfonometilglicil)sulfonilaminas de efecto herbicida.
DK13280A (da) Fremgangsmaade til fremstilling af hexahydro-1,4-oxazepiner
PT84475B (pt) Processo para a preparacao de novos derivados da 1-stireno-sulfonil-2-oxo-5-hidroxi-pirrolidina
ZA801343B (en) Oxadiazolylmethylthiol phosphates
MX162589A (es) Procedimiento para preparar compuestos heterociclicos de 5 miembros conteniendo atomos de n,o o s
SE8402361D0 (sv) Novel acylaminophenol derivatives
ES536139A0 (es) Procedimiento para la preparacion de quinolinonas-4
SE7903233L (sv) Bensylidenestrar
SE8302084D0 (sv) New benzimidazole derivatives
MX11959A (es) Procedimiento de preparacion de nuevos derivados de 1-aril-sulfonil-1, 5-dihidro-2h-pirrol-2-ona y producto obtenido.
MX11977A (es) Derivados de 1-bencil-2-oxo-5-alcoxi-pirrolidina y procedimiento para su preparacion.
IT1254745B (it) Ciclofosfazeni contenenti gruppi di acido acetil salicilico, procedimento di preparazione ed utilizzazione

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970612